Viewing Study NCT07386704


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-31 @ 9:58 AM
Study NCT ID: NCT07386704
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2026-02-04
First Post: 2026-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Sponsor: Peking University First Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module